首页> 外文OA文献 >A Novel Reduced Intensity Conditioning Regimen for Patients with High Risk Hematologic Malignancies Undergoing Conventional Allogeneic Stem Cell Transplantation

【2h】

A Novel Reduced Intensity Conditioning Regimen for Patients with High Risk Hematologic Malignancies Undergoing Conventional Allogeneic Stem Cell Transplantation

机译：一种针对常规异体干细胞移植的高危血液恶性肿瘤患者的新型降低强度条件疗法

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Hobbs Gabriela; Kaur Navjeet; Ponce Doris M.; Hilden Patrick; Castro-Malaspina Hugo; Giralt Sergio A.; Goldberg Jenna D.; Papadopoulos Esperanza; Jakubowski Ann A.; Sauter Craig Steven; Koehne Guenther; Devlin Sean; Barker Juliet N.; Perales Miguel-Angel;
展开▼
作者单位

展开▼
年度 2014
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. A novel reduced intensity conditioning regimen for patients with high-risk hematological malignancies undergoing allogeneic stem cell transplantation [J] . Hobbs G. S., Kaur N., Hilden P., Bone marrow transplantation . 2016,第7期

机译：针对异基因干细胞移植的高危血液恶性肿瘤患者的新型降低强度条件疗法
2. A study of a reduced-intensity conditioning regimen followed by allogeneic stem cell transplantation for patients with hematologic malignancies using Campath-1H as part of a graft-versus-host disease strategy. [J] . Shore T, Harpel J, Schuster MW, Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation . 2006,第8期

机译：使用Campath-1H作为移植物抗宿主疾病策略的一部分，针对血液恶性肿瘤患者进行强度降低的条件疗法后进行同种异体干细胞移植的研究。
3. Melphalan-Based Reduced-Intensity Conditioning is Associated with Favorable Disease Control and Acceptable Toxicities in Patients Older Than 70 with Hematologic Malignancies Undergoing Allogeneic Hematopoietic Stem Cell Transplantation [J] . Monzr M. Al Malki, Nitya Nathwani, Dongyun Yang, Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation . 2018,第9期

机译：基于Melphalan的减少强度调节与70岁的患者有良好的疾病控制和可接受的毒性有关，血液学恶性肿瘤患者经历了同种异体造血干细胞移植
4. Fludarabine Phosphete and Melphalan - An Immunosuppressive Reduced Intensity Conditioning (RIC) Regimen for AUogeneic Stem Cell Transplantation in Patients with a Range of Hematological Malignancies [C] . G. Jackson, C. Richardson, G. Morgan, European Haematology Association . 2002

机译：Fludarabine phospete和Melphalan - 一种免疫抑制性降低的强度调理（RIC）治疗患者血液学恶性肿瘤患者的促孕酮干细胞移植方案
5. Donor selection for patients undergoing allogeneic hematopoietic stem cell transplantation: Assessment of the priorities of Canadian hematopoietic stem cell transplant physicians. [D] . Tay, Jason. 2009

机译：接受同种异体造血干细胞移植的患者的供体选择：加拿大造血干细胞移植医生的优先事项评估。
6. A Novel Reduced Intensity Conditioning Regimen for Patients with High Risk Hematologic Malignancies Undergoing Allogeneic Stem Cell Transplantation [O] . Gabriela S. Hobbs, Navjeet Kaur, Patrick Hilden, -1

机译：一种针对异基因干细胞移植的高危血液恶性肿瘤患者的新型降低强度调节方案
7. An Identical Reduced Intensity Conditioning (RIC) Regimen Prior to Allogeneic (ALLO) Hematopoietic Stem Cell Transplantation (HSCT) in 222 Patients with Hematologic Malignancies: A Monocenter Experience [O] . Blaise Didier, Castagna Luca, Venton Geoffroy, 2013

机译：222例血液系统恶性肿瘤患者同种异体（ALLO）造血干细胞移植（HSCT）之前的同等强度调节（RIC）方案：单中心经验

A Novel Reduced Intensity Conditioning Regimen for Patients with High Risk Hematologic Malignancies Undergoing Conventional Allogeneic Stem Cell Transplantation

著录项

引文网络

相似文献

相关主题

期刊订阅